240
Views
11
CrossRef citations to date
0
Altmetric
Mass Spectrometry

Characterization of Liver Failure by the Analysis of Exhaled Breath by Extractive Electrospray Ionization Mass Spectrometry (EESI-MS): A Pilot Study

, , , , , , , , & show all
Pages 1038-1054 | Received 09 Apr 2020, Accepted 06 Jul 2020, Published online: 16 Jul 2020

References

  • Arasaradnam, R. P., M. McFarlane, K. Ling, S. Wurie, N. O'Connell, C. U. Nwokolo, K. D. Bardhan, J. Skinner, R. S. Savage, and J. A. Covington. 2016. Breathomics-exhaled volatile organic compound analysis to detect hepatic encephalopathy: A pilot study. Journal of Breath Research 10 (1):016012. doi:10.1088/1752-7155/10/1/016012.
  • Arroyo, V., R. Moreau, R. Jalan, and P. Ginès. 2015. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. Journal of Hepatology 62 (1 Suppl):S131–S143. doi:10.1016/j.jhep.2014.11.045.
  • Beccaria, M., T. R. Mellors, J. S. Petion, C. A. Rees, M. Nasir, H. K. Systrom, J. W. Sairistil, M. A. Jean-Juste, V. Rivera, K. Lavoile, et al. 2018. Preliminary investigation of human exhaled breath for tuberculosis diagnosis by multidimensional gas chromatography—Time of flight mass spectrometry and machine learning. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1074–1075:46–50. doi:10.1016/j.jchromb.2018.01.004.
  • Boots, A. W., J. J. Van Berkel, J. W. Dallinga, A. Smolinska, E. F. Wouters, and F. J. van Schooten. 2012. The versatile use of exhaled volatile organic compounds in human health and disease. Journal of Breath Research 6 (2):027108. doi:10.1088/1752-7155/6/2/027108.
  • Chen, H., A. Wortmann, W. Zhang, and R. Zenobi. 2007. Rapid in vivo fingerprinting of nonvolatile compounds in breath by extractive electrospray ionization quadrupole time-of-flight mass spectrometry. Angewandte Chemie (International ed. in English) 46 (4):580–3. doi:10.1002/anie.200602942.
  • Chen, E. Q., F. Zeng, L. Y. Zhou, and H. Tang. 2015. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure. World Journal of Gastroenterology 21 (42):11964–73. doi:10.3748/wjg.v21.i42.11964.
  • Covington, J. A., L. Wedlake, J. Andreyev, N. Ouaret, M. G. Thomas, C. U. Nwokolo, K. D. Bardhan, and R. P. Arasaradnam. 2012. The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: A pilot study. Sensors (Basel, Switzerland) 12 (10):13002–18. doi:10.3390/s121013002.
  • Dadamio, J., S. Van den Velde, W. Laleman, P. Van Hee, W. Coucke, F. Nevens, and M. Quirynen. 2012. Breath biomarkers of liver cirrhosis. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 905:17–22. doi:10.1016/j.jchromb.2012.07.025.
  • Eng, K., Alkhouri, N. F. Cikach, N. Patel, C. Yan, D. Grove, R. Lopez, E. Rome, R. A. Dweik. 2015. Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls. Journal of Breath Research 9 (2):026002. doi:10.1088/1752-7155/9/2/026002.
  • Hanouneh, I. A., N. N. Zein, F. Cikach, L. Dababneh, D. Grove, N. Alkhouri, R. Lopez, and R. A. Dweik. 2014. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clinical Gastroenterology and Hepatology 12 (3):516–23. doi:10.1016/j.cgh.2013.08.048.
  • Hauschild, A. C., T. Frisch, J. I. Baumbach, and J. Baumbach. 2015. Carotta: Revealing hidden confounder markers in metabolic breath profiles. Metabolites 5 (2):344–63. doi:10.3390/metabo5020344.
  • Hu, B., S. Yang, M. Li, H. Gu, and H. Chen. 2011. Direct detection of native proteins in biological matrices using extractive electrospray ionization mass spectrometry. The Analyst 136 (18):3599–601. doi:10.1039/c1an15410a.
  • Li, L., Z. Wu, W. Ma, Y. Yu, and Y. Chen. 2001. Changes in intestinal microflora in patients with chronic severe hepatitis. Chinese Medical Journal 114 (8):869–72.
  • Liang, X., S. Bi, W. Yang, L. Wang, G. Cui, F. Cui, Y. Zhang, J. Liu, X. Gong, Y. Chen, et al. 2009. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27 (47):6550–7. doi:10.1016/j.vaccine.2009.08.048.
  • Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Severe Liver Diseases and Artificial Liver Group, and Chinese Society of Hepatology. 2013. Diagnostic and treatment guidelines for liver failure (2012 version). Zhonghua Gan Zang Bing Za Zhi 21 (3):177–83.
  • McGill, M. R. 2016. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI Journal 15:817–28. doi:10.17179/excli2016-800.
  • Mieth, M., J. K. Schubert, T. Gröger, B. Sabel, S. Kischkel, P. Fuchs, D. Hein, R. Zimmermann, and W. Miekisch. 2010. Automated needle trap heart-cut GC/MS and needle trap comprehensive two-dimensional GC/TOF-MS for breath gas analysis in the clinical environment. Analytical Chemistry 82 (6):2541–51. doi:10.1021/ac100061k.
  • Nitti, M., M. A. Pronzato, U. M. Marinari, and C. Domenicotti. 2008. PKC signaling in oxidative hepatic damage. Molecular Aspects of Medicine 29 (1–2):36–42. doi:10.1016/j.mam.2007.09.001.
  • Obermeier, J., P. Trefz, J. Happ, J. K. Schubert, H. Staude, D. C. Fischer, and W. Miekisch. 2017. Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease. PLoS ONE 12 (6):e0178745. doi:10.1371/journal.pone.0178745.
  • Pan, S., Y. Tian, M. Li, J. Zhao, L. Zhu, W. Zhang, H. Gu, H. Wang, J. Shi, X. Fang, et al. 2015. Quantitative detection of nitricoxide in exhaled human breath by extractive electrospray ionization mass spectrometry. Scientific Reports 5 (1):8725. doi:10.1038/srep08725.
  • Pijls, K. E., A. Smolinska, D. M. Jonkers, J. W. Dallinga, A. A. Masclee, G. H. Koek, and F. van Schooten. 2016. A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis. Scientific Reports 6 (1):19903. doi:10.1038/srep19903.
  • Safari, Z., and P. Gérard. 2019. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cellular and Molecular Life Sciences : CMLS 76 (8):1541–58. doi:10.1007/s00018-019-03011-w.
  • Schwenger, K. J., N. Clermont-Dejean, and J. P. Allard. 2019. The role of the gut microbiome in chronic liver disease: The clinical evidence revised. JHEP Reports 1 (3):214–26. doi:10.1016/j.jhepr.2019.04.004.
  • Smolinska, A., A. C. Hauschild, R. R. Fijten, J. W. Dallinga, J. Baumbach, and F. J. van Schooten. 2014. Current breathomics-a review on data pre-processing techniques and machine learning inmetabolomics breath analysis. Journal of Breath Research 8 (2):027105. doi:10.1088/1752-7155/8/2/027105.
  • Van den Berg, R. A., H. C. Hoefsloot, J. A. Westerhuis, A. K. Smilde, and M. J. Van der Werf. 2006. Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics 7 (1):142. doi:10.1186/1471-2164-7-142.
  • Van den Velde, S., F. Nevens, P. Van Hee, D. van Steenberghe, and M. Quirynen. 2008. GC-MS analysis of breath odor compounds in liver patients. Journal of Chromatography B. 875 (2):344–8. doi:10.1016/j.jchromb.2008.08.031.
  • Verdam, F. J., J. W. Dallinga, A. Driessen, C. de Jonge, E. J. C. Moonen, J. B. N. van Berkel, J. Luijk, N. D. Bouvy, W. A. Buurman, S. S. Rensen, et al. 2013. Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breath. Journal of Hepatology 58 (3):543–8. doi:10.1016/j.jhep.2012.10.030.
  • Wang, C., Y. Feng, M. Wang, X. Pi, H. Tong, Y. Wang, L. Zhu, and E. Li. 2015. Volatile organic metabolites identify patients with mesangial proliferative glomerulonephritis, IgA nephropathy and normal Controls. Scientific Reports 5 (1):14744. doi:10.1038/srep14744.
  • Wang, C., M. Li, H. Jiang, H. Tong, Y. Feng, Y. Wang, X. Pi, L. Guo, M. Nie, H. Feng, et al. 2016. Comparative analysis of VOCs in exhaled breath of amyotrophic lateral sclerosis and cervical spondylotic myelopathy patients. Scientific Reports 6 (1):26120. doi:10.1038/srep26120.
  • Westerhuis, J. A., H. C. J. Hoefsloot, S. Smit, D. J. Vis, A. K. Smilde, E. J. J. van Velzen, J. P. M. van Duijnhoven, and F. A. van Dorste. 2008. Assessment of PLSDA cross validation. Metabolomics 4 (1):81–9. doi:10.1007/s11306-007-0099-6.
  • Wishart, D. S., Feunang, Y. D. A. Marcu, A. C. Guo, K. Liang, R. Vázquez-Fresno, R. T. Sajed, D. Johnson, C. Li, N. Karu, et al. 2018. HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Research 46 (D1):D608–D617. doi:10.1093/nar/gkx1089.
  • Wlodzimirow, K. A., A. Abu-Hanna, M. J. Schultz, M. A. Maas, L. D. Bos, P. J. Sterk, H. H. Knobel, R. J. Soers, and R. A. Chamuleau. 2014. Exhaled breath analysis with electronic nose technology for detection of acute liver failure in rats. Biosensors & Bioelectronics 53:129–34. doi:10.1016/j.bios.2013.09.047.
  • Zuo, W., W. Bai, X. Gan, F. Xu, G. Wen, and W. Zhang. 2019. Detection of Lung Cancer by Analysis of Exhaled Gas Utilizing Extractive Electrospray Ionization-Mass Spectroscopy. Journal of Biomedical Nanotechnology 15 (4):633–46. doi:10.1166/jbn.2019.2719.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.